Eurand, Anesta Sue Anchen Over Generic Amrix

Law360, New York (April 1, 2011, 7:15 PM EDT) -- Eurand Inc. and Anesta AG slapped Anchen Inc. with a patent infringement suit in Delaware on Wednesday over the generic-drug maker's efforts to market a version of the muscle relaxer Amrix.

In a complaint filed in the U.S. District Court for the District of Delaware, Eurand and Anesta claim the submission of an abbreviated new drug application for generic Amrix by Irvine, Calif.-based Anchen and a closely related company, Anchen Pharmaceuticals Inc., infringes two patents. Both Anchen companies are named as defendants in the suit....
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.